Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer displays an updated site revision, from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record now presents detailed information about the completed Phase 3 pancreatic cancer trial, including its treatment groups, participant criteria, measured outcomes, participating locations, and study documents.SummaryDifference100%

- Check22 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA site-wide banner appears above the 403 error page, linking to updates and FAQs about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check36 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, with no change to the study information.SummaryDifference0.2%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.